Intravenous Ferrous Sucrose Versus Oral Ferrous Sulphate in Treatment of Postpartum Iron Difficiency Anaemia: A Randomized Controlled Clinical Trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201602001468135

Enrollment

100

Registered

2016-02-13

Start date

2016-02-13

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility-female

Interventions

intravenous Iron Sucrose

oral Ferrous Sulphate

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Postpartum Iron Difficiency Anaemia with haemoglobin <9g/dL and serum ferritin <15microgram/l

Exclusion criteria

Exclusion criteria: Iron intolerance-asthma-seizures-renal disease-hepatic disease

Design outcomes

Primary

Measure	Time frame
haemoglobi-ferritin-mean corpuscular haemoglobin concentration -haematocrit-red blood indices	—

Secondary

Measure	Time frame
adverse effects of oral and intravenous Iron	—

Countries

Egypt

Contacts

Public Contactnabih elkhouly

lecturer of obstetrics and gynecology department.Faculty of medicine.menoufia university

nabih.elkhouly@yahoo.com01060868443

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026